People
The life science industry is continually making advancements in every area! We want to know what cool science innovations are currently in progress and the professionals behind them.
Stephen Quake, a Stanford University bioengineer and inventor, recently shared several years’ worth of email communications between himself and He with The New York Times.
Although it was probably not in serious jeopardy, Bristol-Myers Squibb’s shareholders voted today to approve the acquisition of Celgene Corporation for about $74 billion.
The biopharma and medtech ecosystem in New Hampshire is growing thanks, in part, to state-supported tax exemptions and an increasing number of regenerative medicine manufacturing companies setting up shop in the Granite State.
Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.
There is a war going on in the health care industry and the enemy is winning. That enemy is bacteria, fungi and other pathogens that have become resistant to treatment with conventional medicines.
Galapagos NV announced that its board of directors created 2,070,000 warrants under new warrant plans for the benefit of the employees, directors, and a consultant of the company and its subsidiaries.
First Light Diagnostics, a developer of breakthrough automated products for the rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, announced the hiring of Andrew Connerty as its vice president of quality assurance and regulatory affairs.
Repairing a damaged organ in order to allow an individual to have a healthier life, as well as a greater quality of life, could soon be a reality as New York-based Angion Biomedica Corp. moves toward completing clinical trials of its lead asset.
Seattle-based Ambry Genetics recently presented data at the American College of Medical Genetics and Genomics annual meeting describing the results of supplemental RNA genetic testing data.
PRESS RELEASES